Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Gaskill CF, Carrier EJ, Kropski JA, Bloodworth NC, Menon S, Foronjy RF, Taketo MM, Hong CC, Austin ED, West JD, Means AL, Loyd JE, Merryman WD, Hemnes AR, De Langhe S, Blackwell TS, Klemm DJ, Majka SM.

J Clin Invest. 2017 Jun 1;127(6):2262-2276. doi: 10.1172/JCI88629. Epub 2017 May 2.

2.

Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.

Gaskill C, Marriott S, Pratap S, Menon S, Hedges LK, Fessel JP, Kropski JA, Ames D, Wheeler L, Loyd JE, Hemnes AR, Roop DR, Klemm DJ, Austin ED, Majka SM.

Pulm Circ. 2016 Dec;6(4):483-497. doi: 10.1086/688314.

3.

The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Wirsdörfer F, Jendrossek V.

Front Immunol. 2016 Dec 14;7:591. doi: 10.3389/fimmu.2016.00591. eCollection 2016. Review.

4.

Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.

Klein D, Steens J, Wiesemann A, Schulz F, Kaschani F, Röck K, Yamaguchi M, Wirsdörfer F, Kaiser M, Fischer JW, Stuschke M, Jendrossek V.

Antioxid Redox Signal. 2017 Apr 10;26(11):563-582. doi: 10.1089/ars.2016.6748. Epub 2016 Nov 14.

5.

Lung Pericytes and Resident Fibroblasts: Busy Multitaskers.

Barron L, Gharib SA, Duffield JS.

Am J Pathol. 2016 Oct;186(10):2519-31. doi: 10.1016/j.ajpath.2016.07.004. Epub 2016 Aug 21. Review.

PMID:
27555112
6.

Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.

Cahill EF, Kennelly H, Carty F, Mahon BP, English K.

Stem Cells Transl Med. 2016 Oct;5(10):1307-1318. Epub 2016 Jul 7.

7.

Mesenchymal stem cells are sensitive to bleomycin treatment.

Nicolay NH, Rühle A, Perez RL, Trinh T, Sisombath S, Weber KJ, Ho AD, Debus J, Saffrich R, Huber PE.

Sci Rep. 2016 May 24;6:26645. doi: 10.1038/srep26645.

8.

Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.

Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW.

Expert Opin Biol Ther. 2016 Jul;16(7):859-71. doi: 10.1517/14712598.2016.1170804. Epub 2016 Apr 12. Review.

10.

Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges.

Mitsialis SA, Kourembanas S.

Semin Perinatol. 2016 Apr;40(3):138-51. doi: 10.1053/j.semperi.2015.12.002. Epub 2016 Jan 15. Review.

11.

Mesenchymal stem cells suppress CaN/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension.

Liu J, Han Z, Han Z, He Z.

Exp Ther Med. 2015 Nov;10(5):1657-1664. Epub 2015 Sep 1.

12.

Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Srour N, Thébaud B.

Stem Cells Transl Med. 2015 Dec;4(12):1500-10. doi: 10.5966/sctm.2015-0121. Epub 2015 Oct 22. Review.

13.

The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases.

Chen J, Li C, Chen L.

Biomed Res Int. 2015;2015:985814. doi: 10.1155/2015/985814. Epub 2015 May 12. Review.

14.

Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.

Skurikhin EG, Pershina OV, Reztsova AM, Ermakova NN, Khmelevskaya ES, Krupin VA, Stepanova IE, Artamonov AV, Bekarev AA, Madonov PG, Dygai AM.

PLoS One. 2015 Apr 30;10(4):e0125065. doi: 10.1371/journal.pone.0125065. eCollection 2015.

15.

An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Weiss DJ, Chambers D, Giangreco A, Keating A, Kotton D, Lelkes PI, Wagner DE, Prockop DJ; ATS Subcommittee on Stem Cells and Cell Therapies.

Ann Am Thorac Soc. 2015 Apr;12(4):S79-97. doi: 10.1513/AnnalsATS.201502-086ST.

16.

ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.

Marriott S, Baskir RS, Gaskill C, Menon S, Carrier EJ, Williams J, Talati M, Helm K, Alford CE, Kropski JA, Loyd J, Wheeler L, Johnson J, Austin E, Nozik-Grayck E, Meyrick B, West JD, Klemm DJ, Majka SM.

Am J Physiol Cell Physiol. 2014 Oct 15;307(8):C684-98. doi: 10.1152/ajpcell.00114.2014.

17.

Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.

West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM.

Am J Physiol Cell Physiol. 2014 Sep 1;307(5):C415-30. doi: 10.1152/ajpcell.00057.2014. Epub 2014 May 28.

18.

MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.

Sdrimas K, Kourembanas S.

Antioxid Redox Signal. 2014 Nov 1;21(13):1905-15. doi: 10.1089/ars.2013.5784. Epub 2014 Feb 24. Review.

19.

Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Weiss DJ.

Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW. Review.

20.

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.

Wang YY, Li XZ, Wang LB.

Stem Cell Res Ther. 2013 May 2;4(3):45. doi: 10.1186/scrt193. Review.

Supplemental Content

Support Center